Induced stem cells

ARM Foundation for Cell and Gene Medicine appoints Jennifer Braswell Executive Director

Retrieved on: 
Tuesday, February 16, 2021

BALTIMORE, Feb. 16, 2021 /PRNewswire/ --The ARM Foundation for Cell and Gene Medicine (ARMF) is pleased to appoint Jennifer Briggs Braswell, PhD as the organization's next Executive Director.

Key Points: 
  • BALTIMORE, Feb. 16, 2021 /PRNewswire/ --The ARM Foundation for Cell and Gene Medicine (ARMF) is pleased to appoint Jennifer Briggs Braswell, PhD as the organization's next Executive Director.
  • Braswell's exceptional work experience gives her a deep knowledge of cell, gene, and regenerative medicine at the national and global levels.
  • Before that, Braswell was the Executive Director of the Sanford Stem Cell Clinical Center at UC San Diego Health.
  • The ARM Foundation for Cell and Gene Medicine serves as the education and information catalyst on issues fundamental to making gene and cell therapies, tissue-engineered products and other regenerative medicine treatments available to patients.

Lineage to Host Virtual OPC1 Investor & Analyst Day on February 22, 2021

Retrieved on: 
Tuesday, February 16, 2021

Interested investors can access the live webcast on the Events and Presentations section of Lineages website.

Key Points: 
  • Interested investors can access the live webcast on the Events and Presentations section of Lineages website.
  • Additional videos are available on the Media page of the Lineage website.
  • Dr. Wirths specialties include clinical trials, translational research, stem cells, cell-based therapies, magnetic resonance imaging, spinal cord injury and neurological disorders.
  • With this platform Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials.

Okayama University research: Therapeutic potential of stem cells for treating neurodegenerative disease

Retrieved on: 
Tuesday, February 16, 2021

Now, Professor ABE Koji and Associate Professor YAMASHITA Toru from Okayama University and colleagues have investigated the potential of a particular kind of stem cells ('Muse cells'), which can recognize damaged sites in the human body, for treating ALS.

Key Points: 
  • Now, Professor ABE Koji and Associate Professor YAMASHITA Toru from Okayama University and colleagues have investigated the potential of a particular kind of stem cells ('Muse cells'), which can recognize damaged sites in the human body, for treating ALS.
  • Muse cells are a kind of stem cell occurring in the bone marrow, blood and connective tissues in the human body.
  • Muse cells can not only locate the damage but also contribute to tissue repair, by transforming (differentiating) into healthy replacement cells.
  • Inspired by this property, Abe and colleagues studied whether there is therapeutic potential in releasing Muse cells in ALS patients.

Okayama University research: Therapeutic potential of stem cells for treating neurodegenerative disease

Retrieved on: 
Tuesday, February 16, 2021

Now, Professor ABE Koji and Associate Professor YAMASHITA Toru from Okayama University and colleagues have investigated the potential of a particular kind of stem cells ('Muse cells'), which can recognize damaged sites in the human body, for treating ALS.

Key Points: 
  • Now, Professor ABE Koji and Associate Professor YAMASHITA Toru from Okayama University and colleagues have investigated the potential of a particular kind of stem cells ('Muse cells'), which can recognize damaged sites in the human body, for treating ALS.
  • Muse cells are a kind of stem cell occurring in the bone marrow, blood and connective tissues in the human body.
  • Muse cells can not only locate the damage but also contribute to tissue repair, by transforming (differentiating) into healthy replacement cells.
  • Inspired by this property, Abe and colleagues studied whether there is therapeutic potential in releasing Muse cells in ALS patients.

India Stem Cell Market Competition Forecast & Opportunities, 2026 by Product Type (Adult; Induced Pluripotent; Human Embryonic), Application (Regenerative Medicine Vs. Drug Discovery & Development) - ResearchAndMarkets.com

Retrieved on: 
Monday, February 15, 2021

The "India Stem Cell Market, By Product Type (Adult; Induced Pluripotent; Human Embryonic; Others), By Application (Regenerative Medicine Vs. Drug Discovery & Development), By End User, By Technology, By Region, Competition Forecast & Opportunities, FY 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "India Stem Cell Market, By Product Type (Adult; Induced Pluripotent; Human Embryonic; Others), By Application (Regenerative Medicine Vs. Drug Discovery & Development), By End User, By Technology, By Region, Competition Forecast & Opportunities, FY 2026" report has been added to ResearchAndMarkets.com's offering.
  • The Indian Stem Cell Market was valued at USD 0.47 Billion in 2019 and is projected to grow at around 13% CAGR during FY 2021 - FY 2026.
  • Continuous advancements in tissue engineering is one of the prime factors boosting the Indian Stem Cell Market.
  • The Indian Stem Cell Market is segmented based on product type, application, technology, end-user and region.

Leading Innovators Collaborate to Provide New, Patient Representative Cell Culture Solutions for Smarter In Vitro Research.

Retrieved on: 
Wednesday, February 10, 2021

With those methods, Cellaria will use cells from its patient-specific cohorts, or other animals, to establish functional and sustainable cell model systems.

Key Points: 
  • With those methods, Cellaria will use cells from its patient-specific cohorts, or other animals, to establish functional and sustainable cell model systems.
  • Cellarias cell models also expand the available platforms on which researchers can build the next generation of personalized therapies.
  • Our authenticated cell models and in-depth cell data directly represent patients reality, resulting in timely and personalized decision making.
  • This collaboration will enable us to provide iPSCs that even more closely represent the original patient environment.

Global 3D Cell Culture Market (2020 to 2027) - by Product, Application, and End-user

Retrieved on: 
Tuesday, February 9, 2021

Furthermore, the 3D cell culture industry is currently facing newer challenges to cope up with the demand and supply of 3D cell culture components owing to the COVID-19 pandemic.

Key Points: 
  • Furthermore, the 3D cell culture industry is currently facing newer challenges to cope up with the demand and supply of 3D cell culture components owing to the COVID-19 pandemic.
  • Thus, the overall COVID-19 impact is anticipated to remain moderate for the prominent players in the 3D cell culture market.
  • Based on application, the 3D cell culture market is divided into cancer research, stem cell research, drug discovery, and regenerative medicine.
  • A comprehensive analysis of the factors that drive and restrain the growth of the global 3D cell culture market is provided.

Worldwide Cell Therapy Industry to 2027 - Profiling Allosource, Medipost and Mesoblast Among Others

Retrieved on: 
Tuesday, February 9, 2021

In addition, growth in aging patient population, The rise in cell therapy transplantations globally, and surge in disease awareness drive growth of the global cell therapy market.

Key Points: 
  • In addition, growth in aging patient population, The rise in cell therapy transplantations globally, and surge in disease awareness drive growth of the global cell therapy market.
  • The global cell therapy market is categorized on the basis of therapy type, therapeutic area, cell type, end user, and region.
  • The global cell therapy market is categorized on the basis of therapy type, therapeutic, cell type, end user and region.
  • On the basis of cell type, it is segregated into stem cell therapy and non-stem cell type.

Outlook on the 3D Cell Culture Global Market to 2027 - Opportunity Analysis and Industry Forecast - ResearchAndMarkets.com

Retrieved on: 
Monday, February 8, 2021

The "3D Cell Culture Market by Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "3D Cell Culture Market by Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering.
  • Furthermore, the 3D cell culture industry is currently facing newer challenges to cope up with the demand and supply of 3D cell culture components owing to the COVID-19 pandemic.
  • Based on application, the 3D cell culture market is divided into cancer research, stem cell research, drug discovery, and regenerative medicine.
  • A comprehensive analysis of the factors that drive and restrain the growth of the global 3D cell culture market is provided.

Kanazawa University research: Going the distance--insights into how cancer cells spread

Retrieved on: 
Monday, February 8, 2021

Genetic mutations found only in some of these cells are known to aid with the spread and progression of cancer.

Key Points: 
  • Genetic mutations found only in some of these cells are known to aid with the spread and progression of cancer.
  • To replicate polyclonal metastasis, AP cells were then co-transplanted with AKTP cells, and voila, both cell types indeed moved into the livers.
  • Instead, when AP cells were injected into the blood (without prior exposure to the AKTP cells) they could not metastasize.
  • Next, AKTP cells within the liver tumors were killed to see how closely that affected the AP cells.